Status:
RECRUITING
Lung Ultrasound in Pediatric Acute Chest Syndrome
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
1-17 years
Brief Summary
Sickle-cell disease is a common disease with serious complications, in particular acute chest syndrome (ACS), which can be life threatening. The pathophysiology of ACS is poorly understood, but alveol...
Detailed Description
Scientific rationale: Sickle-cell disease is a frequent disorder with a high morbidity. Its course is marked by acute complications with a life-threatening and functional prognosis, principally acute ...
Eligibility Criteria
Inclusion
- Sickle cell disease patient aged 1 month to 17 years
- Hospitalisation in the PICU of Robert-Debre hospital
- Suspicion of acute chest syndrome ACS
- No objection from a legal representative or the child taken in by the doctor.
Exclusion
- Refusal of parents
- Delay between first LUS and initiation of ventilator support greater than 6 hours
- Patient without social insurance
Key Trial Info
Start Date :
June 30 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06497153
Start Date
June 30 2024
End Date
September 30 2026
Last Update
July 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert Debré hOSPITAL
Paris, France, 75019